Notable earnings after Thursday's close
Seeking Alpha News (Wed, 27-Mar 5:35 PM ET)
ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024
Business Wire (Thu, 21-Mar 8:00 AM ET)
ENDRA Life Sciences Installs First TAEUS System in the UK
Business Wire (Tue, 27-Feb 8:00 AM ET)
Business Wire (Wed, 21-Feb 8:00 AM ET)
Business Wire (Wed, 14-Feb 8:30 AM ET)
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
Endra Life Sciences trades on the NASDAQ stock market under the symbol NDRA.
As of March 28, 2024, NDRA stock price declined to $0.57 with 898,965 million shares trading.
NDRA has a beta of 0.70, meaning it tends to be less sensitive to market movements. NDRA has a correlation of 0.01 to the broad based SPY ETF.
NDRA has a market cap of $6.29 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, NDRA stock traded as high as $1,120.00 and as low as $.57.
The top ETF exchange traded funds that NDRA belongs to (by Net Assets): VXF.
NDRA has underperformed the market in the last year with a price return of -78.7% while the SPY ETF gained +33.9%. NDRA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -71.2% and -46.7%, respectively, while the SPY returned +10.3% and +1.9%, respectively.
NDRA support price is $.77 and resistance is $.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NDRA stock will trade within this expected range on the day.